Thermo Fisher Scientific (TMO)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
$516.48-0.22%
Close 2026-07-07 · 1-day change
Reading TMO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TMO free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-07
Reading TMO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TMO free→Thermo Fisher grows sales about 7% a year, helped by acquisitions like Clario. Profit margins stay solid with EPS near $25 in 2026. Cash from operations rose from $723 million to $1.192 billion in one year. The company keeps buying back shares to return capital.
Growth could slow if acquisitions like Clario do not integrate well. Profit margins might weaken if costs rise or demand softens. Cash flow growth could stall, limiting share buybacks and investments.
The price is about 8% above our fair value near $479 and below the Street median of $555. Analysts expect about 7.5% revenue growth, which aligns with recent trends. Our view is more cautious than the Street on valuation but agrees on steady growth.
Breaks if: No buyback program announced or executed in next year
Initiate a share buyback program to optimize capital allocation.
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Quarterly cash from operations falls below $1 billion
Focus on increasing cash generated from operating activities.
Stated in 2 of last 2 quarters. Cash from operating activities increased from $723 million in 2025-Q1 to $1.192 billion in 2026-Q1, showing a positive trajectory in operational cash flow generation.
“Cash from operating activities increased to $1.192 billion.”
“Cash from operating activities was $723 million.”
Breaks if: EPS falls below $23 next year
Breaks if: YoY revenue growth falls below 5% next year
Focus on finalizing the acquisition of Clario Holdings to enhance growth.